Apnimed, Inc. (APMD)
NMS · Healthcare · Biotechnology
$18.53
-1.96%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$771.4M
Shares Outstanding
41.6M
P/S (TTM)
6.6x
P/E (TTM)
9.9x
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 3.1M | 17.1M | 84.8M | 12.1M |
| Gross Profit | 1.8M | 15.4M | 82.7M | 10.9M |
| Operating Income | (27.1M) | (5.9M) | 68.0M | (11.7M) |
| Net Income | (28.6M) | (69.5M) | 70.4M | 125.9M |
| Diluted EPS | $-1.00 | $-2.42 | $2.12 | $3.16 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 8.0M | 38.5M |
| Gross Profit | 4.6M | 31.8M |
| Operating Income | (114.2M) | (53.8M) |
| Net Income | (111.3M) | (932K) |
| Diluted EPS | $-3.87 | $-0.03 |